{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:42:43Z","timestamp":1768477363501,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11886-018-0976-9","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T08:52:49Z","timestamp":1521881569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?"],"prefix":"10.1007","volume":"20","author":[{"given":"Vincent","family":"Algalarrondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve","family":"Piekarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludivine","family":"Eliahou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Le Guludec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel S.","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Rouzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"key":"976_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","volume":"34","author":"C Rapezzi","year":"2013","unstructured":"Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, et al. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J. 2013;34:520\u20138.","journal-title":"Eur Heart J"},{"key":"976_CR2","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","volume":"112","author":"RH Falk","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047\u201360.","journal-title":"Circulation"},{"key":"976_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","volume":"70","author":"A Martinez-Naharro","year":"2017","unstructured":"Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70:466\u201377.","journal-title":"J Am Coll Cardiol"},{"key":"976_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","volume":"38","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2017","unstructured":"Gonz\u00e1lez-L\u00f3pez E, Gagliardi C, Dominguez F, Quarta CC, de Haro-Del Moral FJ, Milandri A, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. Eur Heart J. 2017;38:1895\u2013904.","journal-title":"Eur Heart J"},{"key":"976_CR5","first-page":"1442","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P, Popovi\u0107 ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart Br Card Soc. 2012;98:1442\u20138.","journal-title":"Heart Br Card Soc"},{"key":"976_CR6","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, Cooke RMT, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46:1076\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"976_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","volume":"38","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2011;38:470\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"976_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"Bokhari S, Casta\u00f1o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195\u2013201.","journal-title":"Circ Cardiovasc Imaging"},{"key":"976_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley A-M, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging. 2014;15:1289\u201398.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"976_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016;1:880\u20139.","journal-title":"JAMA Cardiol"},{"key":"976_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc. Imaging. 2011;4:659\u201370.","journal-title":"JACC Cardiovasc. Imaging."},{"key":"976_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"\u2022\u2022 Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404\u201312. Validation of the diagnostic value of bone scintigraphy in TTR-CA in a multicenter study.","journal-title":"Circulation"},{"key":"976_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","volume":"7","author":"S Longhi","year":"2014","unstructured":"Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, et al. Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. JACC Cardiovasc. Imaging. 2014;7:531\u20132.","journal-title":"JACC Cardiovasc. Imaging."},{"key":"976_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jcmg.2014.03.002","volume":"7","author":"AV Kristen","year":"2014","unstructured":"Kristen AV, Scherer K, Buss S, Aus dem Siepen F, Haufe S, Bauer R, et al. Noninvasive risk stratification of patients with transthyretin amyloidosis. JACC Cardiovasc. Imaging. 2014;7:502\u201310.","journal-title":"JACC Cardiovasc. Imaging."},{"key":"976_CR15","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R, et al. Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. JACC Cardiovasc Imaging. 2018;11(2 Pt 1):234\u201342. \n                      https:\/\/doi.org\/10.1016\/j.jcmg.2017.06.020\n                      \n                    . First description of the apical sparring pattern with bone scintigraphy in TTR-CA.","DOI":"10.1016\/j.jcmg.2017.06.020"},{"key":"976_CR16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12350-015-0287-0","volume":"23","author":"A Gucht Van Der","year":"2016","unstructured":"Van Der Gucht A, Galat A, Rosso J, Guellich A, Garot J, Bodez D, et al. [18F]-NaF PET\/CT imaging in cardiac amyloidosis. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2016;23:846\u20139.","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"976_CR17","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","volume":"68","author":"MG Trivieri","year":"2016","unstructured":"Trivieri MG, Dweck MR, Abgral R, Robson PM, Karakatsanis NA, Lala A, et al. (18)F-sodium fluoride PET\/MR for the assessment of cardiac amyloidosis. J Am Coll Cardiol. 2016;68:2712\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"976_CR18","first-page":"213","volume":"54","author":"G Antoni","year":"2013","unstructured":"Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsj\u00f6 L, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. 2013;54:213\u201320.","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"976_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"S-P Lee","year":"2015","unstructured":"Lee S-P, Lee ES, Choi H, Im H-J, Koh Y, Lee M-H, et al. 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc. Imaging. 2015;8:50\u20139.","journal-title":"JACC Cardiovasc. Imaging."},{"key":"976_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR, Di Carli MF, et al. Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41:1652\u201362.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"976_CR21","doi-asserted-by":"publisher","unstructured":"Park MA, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, et al. 18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study. Circ Cardiovasc Imaging. 2015;8(8):e002954. \n                      https:\/\/doi.org\/10.1161\/CIRCIMAGING.114.002954\n                      \n                    .","DOI":"10.1161\/CIRCIMAGING.114.002954"},{"key":"976_CR22","first-page":"1733","volume":"57","author":"WP Law","year":"2016","unstructured":"Law WP, Wang WYS, Moore PT, Mollee PN, Ng ACT. Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study. J Nucl Med Off Publ Soc Nucl Med. 2016;57:1733\u20139.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"976_CR23","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1161\/hc4901.100380","volume":"104","author":"N Delahaye","year":"2001","unstructured":"Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, et al. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation. 2001;104:2911\u20136.","journal-title":"Circulation"},{"key":"976_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jcmg.2016.07.008","volume":"9","author":"V Algalarrondo","year":"2016","unstructured":"\u2022\u2022 Algalarrondo V, Antonini T, Th\u00e9audin M, Chemla D, Benmalek A, Lacroix C, et al. Cardiac dysautonomia predicts long-term survival in hereditary transthyretin amyloidosis after liver transplantation. JACC Cardiovasc. Imaging. 2016;9:1432\u201341. Prognostic value of cardiac MIBG scintigraphy after liver transplantation.","journal-title":"JACC Cardiovasc. Imaging."},{"key":"976_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","volume":"29","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol. 1997;29:168\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"976_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s002590050406","volume":"26","author":"N Delahaye","year":"1999","unstructured":"Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med. 1999;26:416\u201324.","journal-title":"Eur J Nucl Med"},{"key":"976_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.md.0000232559.22098.c3","volume":"85","author":"N Delahaye","year":"2006","unstructured":"Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore). 2006;85:229\u201338.","journal-title":"Medicine (Baltimore)"},{"key":"976_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MCA Coutinho","year":"2013","unstructured":"Coutinho MCA, Cortez-Dias N, Cantinho G, Concei\u00e7\u00e3o I, Oliveira A, Bordalo e S\u00e1 A, et al. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging. 2013;6:627\u201336.","journal-title":"Circ Cardiovasc Imaging"},{"key":"976_CR29","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00415-007-0617-5","volume":"254","author":"C Denier","year":"2007","unstructured":"Denier C, Ducot B, Husson H, Lozeron P, Adams D, Meyer L, et al. A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy. J Neurol. 2007;254:1684\u20138.","journal-title":"J Neurol"},{"key":"976_CR30","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","volume":"116","author":"D Feng","year":"2007","unstructured":"Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007;116:2420\u20136.","journal-title":"Circulation"},{"key":"976_CR31","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"976_CR32","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.hrthm.2012.02.033","volume":"9","author":"V Algalarrondo","year":"2012","unstructured":"Algalarrondo V, Dinanian S, Juin C, Chemla D, Bennani SL, Sebag C, et al. Prophylactic pacemaker implantation in familial amyloid polyneuropathy. Heart Rhythm. 2012;9:1069\u201375.","journal-title":"Heart Rhythm"},{"key":"976_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","volume":"222","author":"D Hamon","year":"2016","unstructured":"Hamon D, Algalarrondo V, Gandjbakhch E, Extramiana F, Marijon E, Elbaz N, et al. Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis. Int J Cardiol. 2016;222:562\u20138.","journal-title":"Int J Cardiol"},{"key":"976_CR34","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"},{"key":"976_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/00007890-200203150-00015","volume":"73","author":"B-O Olofsson","year":"2002","unstructured":"Olofsson B-O, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation. 2002;73:745\u201351.","journal-title":"Transplantation"},{"key":"976_CR36","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","volume":"99","author":"B-G Ericzon","year":"2015","unstructured":"Ericzon B-G, Wilczek HE, Larsson M, Wijayatunga P, Stangou A, Pena JR, et al. Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative? Transplantation. 2015;99:1847\u201354.","journal-title":"Transplantation"},{"key":"976_CR37","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.jacc.2015.08.870","volume":"66","author":"V Algalarrondo","year":"2015","unstructured":"Algalarrondo V, Antonini T, Th\u00e9audin M, Ducot B, Lozeron P, Chemla D, et al. Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2154\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"976_CR38","doi-asserted-by":"publisher","unstructured":"Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2017. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehx589\n                      \n                    .","DOI":"10.1093\/eurheartj\/ehx589"},{"key":"976_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jcmg.2014.03.007","volume":"7","author":"E Arbustini","year":"2014","unstructured":"Arbustini E, Merlini G. Early identification of transthyretin-related hereditary cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:511\u20134.","journal-title":"JACC Cardiovasc Imaging"},{"key":"976_CR40","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","volume":"39","author":"W Noordzij","year":"2012","unstructured":"Noordzij W, Glaudemans AWJM, van Rheenen RWJ, Hazenberg BPC, Tio RA, Dierckx RAJO, et al. (123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis. Eur J Nucl Med Mol Imaging. 2012;39:1609\u201317.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"976_CR41","doi-asserted-by":"publisher","unstructured":"Piekarski E, Chequer R, Algalarrondo V, Eliahou L, Mahida B, Vigne J, et al. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonates scintigraphy in TTR mutation carriers. Eur J Nucl Med Mol Imaging. 2018. \n                      https:\/\/doi.org\/10.1007\/s00259-018-3963-x\n                      \n                    .","DOI":"10.1007\/s00259-018-3963-x"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-018-0976-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-0976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-0976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T00:29:40Z","timestamp":1553387380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-018-0976-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s11886-018-0976-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,24]]},"assertion":[{"value":"24 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Eve Piekarski and Ludivine Eliahou declare that they have no conflict of interest.Vincent Algalarrondo reports grants from Medtronic, St. Jude Medical, Sorin, and Boston Scientific.Fran\u00e7ois Rouzet reports grants from Alnylam and General Electrics.Dominique Le Guludec reports grants from GE Healthcare, Alnylam, and Advanced Accelerator Application.Michel S. Slama has received consulting fees from Pfizer, Alnylam, and Eidos, and his department has received a grant from Ionis-GSK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"33"}}